JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.

Call Us 1 - 866 - 986 - 9598
[email protected]

Sign Up

Login
- My Order
- Return Requests
- Track my Order

Home / Proteins & Peptide

Spike S1 (B.1.617.2.1, Delta Plus Variant) Avi-His-Tag (SARS-CoV-2)

SKU : BHP18201046

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Request More Infos

BPS Bioscience

view supplier details

Order Now

Credit card payments now incur a 3% fee.

Contact us to order

Tel

+1 866.986.9598

Email

[email protected]

Get a Quote

Ask Merchant

Request More Infos

Sample Request

Mfr.No.	101179
Description	Recombinant SARS-CoV-2 Spike protein S1 subunit, encompassing amino acids 16-685. This protein corresponds to SARS-CoV-2 Variant B.1.617.2.1 also known as variant Delta Plus originally identified in India, and contains mutations T19R, G142D, R158G, L452R, K417N, T478K D614G and P681R as well as deletion E156/F157. It was constructed with a C-terminal Avi-Tag followed by a His-tag (6xHis). The protein was affinity purified. Constructs: Spike S1 (B.1.617.2.1 Variant) (16-685-Avi-His) (SARS-CoV-2)
Immunogen Region	16-685
Tag	C-terminal Avi-His-tag
Formulation	8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, 20% glycerol
Species	SARS-CoV-2
Notes	Avoid freeze/thaw cycles.
GenBank	MN908947
Mw(kda)	78 kDa + glycans

Synonyms	coronavirus, covid, covid-19, covid19, Sars-cov-2 p1, sars cov 2 Spike, sarscov2, SARS-CoV-2 variant b161721, Lineage B.1.617.2.1, B161721 mutation, India coronavirus, India variant, Delta plus, Delta Plus variant
Uniprot	P0DTC2

Shipping Temperature	-80°C (dry ice)
Format	Aqueous buffer solution
Purity	>=90%
Storage	At least 6 months at -80°C.

Product Manual	Datasheet

Have you used this product?

Rate it now..!!

Login to Review

SKU	Supplier No.	Size	Your price	Quantity
BHP18201046	101179	100 ug	$352		Add to Cart

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.

© 2024 Biohippo. All rights reserved.